Drug Testing Technologies Market Report

Drug Testing Technologies Market - Global Professional Analysis and Forecast to 2026

  • POSTDATE：Oct 14, 2019
  • PAGES：207
  • REPORT CODE：GMM320325
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The worldwide Drug Testing Technologies market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.6% during the forecast period.

    This report presents the market size and development trends by detailing the Drug Testing Technologies market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Drug Testing Technologies market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Drug Testing Technologies industry and will help you to build a panoramic view of the industrial development.

    Drug Testing Technologies Market, By Type:

    • Single-Parameter Test

    • Multi-Parameter Test

    Drug Testing Technologies Market, By Application:

    • Onsite Testing

    • Laboratory Testing

    Some of the leading players are as follows:

    • Biophor Diagnostics

    • Abbott Diagnostics

    • Hoffmann-La Roche, Ltd.

    • Alfa Scientific

    • Lifesign

    • Identa Corp

    • Branan Medical Corp

    • Devon Medical Products

    • American Bio Medica

    • Accutech

    • Bio-Rad Laboratories

    • Quest Diagnostics International Inc.

    • Lifeloc Technologies

    • Alere

    • Bioscan Screening Systems

    • Beckman Coulter

    • Concateno, Plc

    • 1 Step Detect Associates

    • Agilent Technologies

    • Confirm Biosciences

    • Acon Laboratories

    • Elitech Group

    • Atlas Link Biotech

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 Drug Testing Technologies Market: Technology Type Analysis

    • 4.1 Drug Testing Technologies Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 Drug Testing Technologies Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 Single-Parameter Test

      • 4.3.2 Multi-Parameter Test

    5 Drug Testing Technologies Market: Product Analysis

    • 5.1 Drug Testing Technologies Product Market Share Analysis, 2018 & 2026

    • 5.2 Drug Testing Technologies Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 Drug Testing Technologies Market: Application Analysis

    • 6.1 Drug Testing Technologies Application Market Share Analysis, 2018 & 2026

    • 6.2 Drug Testing Technologies Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 Onsite Testing

      • 6.3.2 Laboratory Testing

    7 Drug Testing Technologies Market: Regional Analysis

    • 7.1 Drug Testing Technologies Regional Market Share Analysis, 2018 & 2026

    • 7.2 Drug Testing Technologies Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 Biophor Diagnostics

      • 9.1.1 Biophor Diagnostics Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 Abbott Diagnostics

      • 9.2.1 Abbott Diagnostics Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 Hoffmann-La Roche, Ltd.

      • 9.3.1 Hoffmann-La Roche, Ltd. Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 Alfa Scientific

      • 9.4.1 Alfa Scientific Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 Lifesign

      • 9.5.1 Lifesign Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

    • 9.6 Identa Corp

      • 9.6.1 Identa Corp Company overview

      • 9.6.2 Financial performance

      • 9.6.3 Product benchmarking

      • 9.6.4 Strategic initiatives

      • 9.6.5 SWOT analysis

    • 9.7 Branan Medical Corp

      • 9.7.1 Branan Medical Corp Company overview

      • 9.7.2 Financial performance

      • 9.7.3 Product benchmarking

      • 9.7.4 Strategic initiatives

      • 9.7.5 SWOT analysis

    • 9.8 Devon Medical Products

      • 9.8.1 Devon Medical Products Company overview

      • 9.8.2 Financial performance

      • 9.8.3 Product benchmarking

      • 9.8.4 Strategic initiatives

      • 9.8.5 SWOT analysis

    • 9.9 American Bio Medica

      • 9.9.1 American Bio Medica Company overview

      • 9.9.2 Financial performance

      • 9.9.3 Product benchmarking

      • 9.9.4 Strategic initiatives

      • 9.9.5 SWOT analysis

    • 9.10 Accutech

      • 9.10.1 Accutech Company overview

      • 9.10.2 Financial performance

      • 9.10.3 Product benchmarking

      • 9.10.4 Strategic initiatives

      • 9.10.5 SWOT analysis

    • 9.11 Bio-Rad Laboratories

      • 9.11.1 Bio-Rad Laboratories Company overview

      • 9.11.2 Financial performance

      • 9.11.3 Product benchmarking

      • 9.11.4 Strategic initiatives

      • 9.11.5 SWOT analysis

    • 9.12 Quest Diagnostics International Inc.

      • 9.12.1 Quest Diagnostics International Inc. Company overview

      • 9.12.2 Financial performance

      • 9.12.3 Product benchmarking

      • 9.12.4 Strategic initiatives

      • 9.12.5 SWOT analysis

    • 9.13 Lifeloc Technologies

      • 9.13.1 Lifeloc Technologies Company overview

      • 9.13.2 Financial performance

      • 9.13.3 Product benchmarking

      • 9.13.4 Strategic initiatives

      • 9.13.5 SWOT analysis

    • 9.14 Alere

      • 9.14.1 Alere Company overview

      • 9.14.2 Financial performance

      • 9.14.3 Product benchmarking

      • 9.14.4 Strategic initiatives

      • 9.14.5 SWOT analysis

    • 9.15 Bioscan Screening Systems

      • 9.15.1 Bioscan Screening Systems Company overview

      • 9.15.2 Financial performance

      • 9.15.3 Product benchmarking

      • 9.15.4 Strategic initiatives

      • 9.15.5 SWOT analysis

    • 9.16 Beckman Coulter

      • 9.16.1 Beckman Coulter Company overview

      • 9.16.2 Financial performance

      • 9.16.3 Product benchmarking

      • 9.16.4 Strategic initiatives

      • 9.16.5 SWOT analysis

    • 9.17 Concateno, Plc

      • 9.17.1 Concateno, Plc Company overview

      • 9.17.2 Financial performance

      • 9.17.3 Product benchmarking

      • 9.17.4 Strategic initiatives

      • 9.17.5 SWOT analysis

    • 9.18 1 Step Detect Associates

      • 9.18.1 1 Step Detect Associates Company overview

      • 9.18.2 Financial performance

      • 9.18.3 Product benchmarking

      • 9.18.4 Strategic initiatives

      • 9.18.5 SWOT analysis

    • 9.19 Agilent Technologies

      • 9.19.1 Agilent Technologies Company overview

      • 9.19.2 Financial performance

      • 9.19.3 Product benchmarking

      • 9.19.4 Strategic initiatives

      • 9.19.5 SWOT analysis

    • 9.20 Confirm Biosciences

      • 9.20.1 Confirm Biosciences Company overview

      • 9.20.2 Financial performance

      • 9.20.3 Product benchmarking

      • 9.20.4 Strategic initiatives

      • 9.20.5 SWOT analysis

    • 9.21 Acon Laboratories

      • 9.21.1 Acon Laboratories Company overview

      • 9.21.2 Financial performance

      • 9.21.3 Product benchmarking

      • 9.21.4 Strategic initiatives

      • 9.21.5 SWOT analysis

    • 9.22 Elitech Group

      • 9.22.1 Elitech Group Company overview

      • 9.22.2 Financial performance

      • 9.22.3 Product benchmarking

      • 9.22.4 Strategic initiatives

      • 9.22.5 SWOT analysis

    • 9.23 Atlas Link Biotech

      • 9.23.1 Atlas Link Biotech Company overview

      • 9.23.2 Financial performance

      • 9.23.3 Product benchmarking

      • 9.23.4 Strategic initiatives

      • 9.23.5 SWOT analysis

     

    The List of Tables and Figures (Totals 61 Figures and 159 Tables)

    • Figure Single-Parameter Test Drug Testing Technologies market, 2015 - 2026 (USD Million)

    • Figure Multi-Parameter Test Drug Testing Technologies market, 2015 - 2026 (USD Million)

    • Figure Onsite Testing market, 2015 - 2026 (USD Million)

    • Figure Laboratory Testing market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America Drug Testing Technologies market, by country, 2015 - 2026 (USD Million)

    • Table North America Drug Testing Technologies market, by type, 2015 - 2026 (USD Million)

    • Table North America Drug Testing Technologies market, by product, 2015 - 2026 (USD Million)

    • Table North America Drug Testing Technologies market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. Drug Testing Technologies market, by type, 2015 - 2026 (USD Million)

    • Table U.S. Drug Testing Technologies market, by product, 2015 - 2026 (USD Million)

    • Table U.S. Drug Testing Technologies market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada Drug Testing Technologies market, by type, 2015 - 2026 (USD Million)

    • Table Canada Drug Testing Technologies market, by product, 2015 - 2026 (USD Million)

    • Table Canada Drug Testing Technologies market, by application, 2015 - 2026 (USD Million)

    • Table Europe Drug Testing Technologies market, by country, 2015 - 2026 (USD Million)

    • Table Europe Drug Testing Technologies market, by type, 2015 - 2026 (USD Million)

    • Table Europe Drug Testing Technologies market, by product, 2015 - 2026 (USD Million)

    • Table Europe Drug Testing Technologies market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. Drug Testing Technologies market, by type, 2015 - 2026 (USD Million)

    • Table U.K. Drug Testing Technologies market, by product, 2015 - 2026 (USD Million)

    • Table U.K. Drug Testing Technologies market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany Drug Testing Technologies market, by type, 2015 - 2026 (USD Million)

    • Table Germany Drug Testing Technologies market, by product, 2015 - 2026 (USD Million)

    • Table Germany Drug Testing Technologies market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France Drug Testing Technologies market, by type, 2015 - 2026 (USD Million)

    • Table France Drug Testing Technologies market, by product, 2015 - 2026 (USD Million)

    • Table France Drug Testing Technologies market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy Drug Testing Technologies market, by type, 2015 - 2026 (USD Million)

    • Table Italy Drug Testing Technologies market, by product, 2015 - 2026 (USD Million)

    • Table Italy Drug Testing Technologies market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain Drug Testing Technologies market, by type, 2015 - 2026 (USD Million)

    • Table Spain Drug Testing Technologies market, by product, 2015 - 2026 (USD Million)

    • Table Spain Drug Testing Technologies market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific Drug Testing Technologies market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific Drug Testing Technologies market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific Drug Testing Technologies market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific Drug Testing Technologies market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China Drug Testing Technologies market, by type, 2015 - 2026 (USD Million)

    • Table China Drug Testing Technologies market, by product, 2015 - 2026 (USD Million)

    • Table China Drug Testing Technologies market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan Drug Testing Technologies market, by type, 2015 - 2026 (USD Million)

    • Table Japan Drug Testing Technologies market, by product, 2015 - 2026 (USD Million)

    • Table Japan Drug Testing Technologies market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India Drug Testing Technologies market, by type, 2015 - 2026 (USD Million)

    • Table India Drug Testing Technologies market, by product, 2015 - 2026 (USD Million)

    • Table India Drug Testing Technologies market, by application, 2015 - 2026 (USD Million)

    • Table Latin America Drug Testing Technologies market, by country, 2015 - 2026 (USD Million)

    • Table Latin America Drug Testing Technologies market, by type, 2015 - 2026 (USD Million)

    • Table Latin America Drug Testing Technologies market, by product, 2015 - 2026 (USD Million)

    • Table Latin America Drug Testing Technologies market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil Drug Testing Technologies market, by type, 2015 - 2026 (USD Million)

    • Table Brazil Drug Testing Technologies market, by product, 2015 - 2026 (USD Million)

    • Table Brazil Drug Testing Technologies market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico Drug Testing Technologies market, by type, 2015 - 2026 (USD Million)

    • Table Mexico Drug Testing Technologies market, by product, 2015 - 2026 (USD Million)

    • Table Mexico Drug Testing Technologies market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina Drug Testing Technologies market, by type, 2015 - 2026 (USD Million)

    • Table Argentina Drug Testing Technologies market, by product, 2015 - 2026 (USD Million)

    • Table Argentina Drug Testing Technologies market, by application, 2015 - 2026 (USD Million)

    • Table MEA Drug Testing Technologies market, by country, 2015 - 2026 (USD Million)

    • Table MEA Drug Testing Technologies market, by type, 2015 - 2026 (USD Million)

    • Table MEA Drug Testing Technologies market, by product, 2015 - 2026 (USD Million)

    • Table MEA Drug Testing Technologies market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa Drug Testing Technologies market, by type, 2015 - 2026 (USD Million)

    • Table South Africa Drug Testing Technologies market, by product, 2015 - 2026 (USD Million)

    • Table South Africa Drug Testing Technologies market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria Drug Testing Technologies market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria Drug Testing Technologies market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria Drug Testing Technologies market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table Biophor Diagnostics Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Abbott Diagnostics Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Hoffmann-La Roche, Ltd. Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Alfa Scientific Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Lifesign Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Identa Corp Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Branan Medical Corp Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Devon Medical Products Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table American Bio Medica Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Accutech Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Bio-Rad Laboratories Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Quest Diagnostics International Inc. Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Lifeloc Technologies Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Alere Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Bioscan Screening Systems Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Beckman Coulter Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Concateno, Plc Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table 1 Step Detect Associates Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Agilent Technologies Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Confirm Biosciences Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Acon Laboratories Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Elitech Group Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Atlas Link Biotech Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US